Filing Details
- Accession Number:
- 0001140361-15-035230
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-16 17:56:39
- Reporting Period:
- 2015-09-15
- Filing Date:
- 2015-09-16
- Accepted Time:
- 2015-09-16 17:56:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1572552 | Asterias Biotherapeutics Inc. | AST | Biological Products, (No Disgnostic Substances) (2836) | 461047971 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1187035 | Jane Lebkowski | 230 Constitution Drive Menlo Park CA 94025 | President Of R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Series A Common Stock | Disposition | 2015-09-15 | 4,912 | $6.00 | 476 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The shares reported herein were sold pursuant to a Rule 10b5-1 Plan adopted by the reporting person on June 30, 2015.